9-14116333-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001190737.2(NFIB):c.1259G>A(p.Gly420Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000733 in 1,365,186 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_001190737.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000820 AC: 1AN: 122018Hom.: 0 AF XY: 0.0000153 AC XY: 1AN XY: 65186
GnomAD4 exome AF: 7.33e-7 AC: 1AN: 1365186Hom.: 0 Cov.: 31 AF XY: 0.00000149 AC XY: 1AN XY: 671394
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
NFIB-related disorder Uncertain:1
The NFIB c.1259G>A variant is predicted to result in the amino acid substitution p.Gly420Asp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0021% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at